SCHIZOPHRENIA DRUG NONCOMPLIANCE MAY LEAD TO ONE-THIRD OF HOSPITAL COSTS
SCHIZOPHRENIA DRUG NONCOMPLIANCE MAY LEAD TO ONE-THIRD OF HOSPITAL COSTS during short stays associated with the disease, Peter Weiden, MD, St. Lukes-Roosevelt Hospital Center, suggested Nov. 7 at an American Medical Association Science Reporters Conference in Seattle. Weiden and Mark Olsson, MD, Columbia University, looked at the effect on readmission rates of drug discontinuation after discharge and found that relapse rates among schizophrenics following hospitalization increased from 3.5% to 12% per month after patients stopped their medication.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth